Literature DB >> 19549973

Migraine headache in middle age and late-life brain infarcts.

Ann I Scher1, Larus S Gudmundsson, Sigurdur Sigurdsson, Anna Ghambaryan, Thor Aspelund, Gudny Eiriksdottir, Mark A van Buchem, Vilmundur Gudnason, Lenore J Launer.   

Abstract

CONTEXT: Migraine is considered to be an episodic condition with no long-term consequences. However, recent studies suggest that migraine attacks may be associated with pathologic changes in the brain, particularly in the cerebellum.
OBJECTIVE: To determine whether individuals not reporting headache compared with individuals reporting migraine symptoms, particularly aura, in midlife are at increased risk of late-life infarct-like lesions found on magnetic resonance imaging (MRI) without consideration of clinical symptoms. DESIGN, SETTING, AND PARTICIPANTS: A population-based study of men and women in Reykjavik, Iceland (cohort born 1907-1935; n = 4689; 57% women) were followed up since 1967, examined, and interviewed about migraine symptoms in midlife (mean age, 51 years; range, 33-65 years). Between 2002 and 2006, more than 26 years later, brain MRIs were performed. Participants reporting headaches once or more per month were asked about migraine symptoms including nausea, unilateral location, photophobia, visual disturbance, and numbness. These individuals with headache were classified as having migraine without aura, migraine with aura, or nonmigraine headache. A comprehensive cardiovascular risk assessment was performed at both examinations. MAIN OUTCOME MEASURE: Presence of infarct-like lesions (total) and specifically located in the cortical, subcortical, and cerebellar regions.
RESULTS: Infarct-like lesions were present in 39.3% of men and 24.6% of women. After adjusting for age, sex, and follow-up time, compared with those not reporting headaches once or more per month (n = 3243), those with midlife migraine with aura (n = 361) had an increased risk of late-life infarct-like lesions (adjusted odds ratio [OR], 1.4; 95% confidence interval [CI], 1.1-1.8) that specifically reflected an association with cerebellar lesions in women (prevalence of infarcts 23.0% for women with migraine with aura vs 14.5% for women not reporting headaches; adjusted OR, 1.9; 95% CI, 1.4-2.6 vs a 19.3% prevalence of infarcts for men with migraine with aura vs 21.3% for men not reporting headaches; adjusted OR, 1.0; 95% CI, 0.6-1.8; P<.04 for interaction by sex). Migraine without aura and nonmigraine headache were not associated with an increased risk.
CONCLUSIONS: Migraine with aura in midlife was associated with late-life prevalence of cerebellar infarct-like lesions on MRI. This association was statistically significant only for women. This is consistent with the hypothesis that migraine with aura in midlife is associated with late-life vascular disease in the cerebellum and in women.

Entities:  

Mesh:

Year:  2009        PMID: 19549973      PMCID: PMC3133433          DOI: 10.1001/jama.2009.932

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  32 in total

1.  The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel.

Authors:  A Ducros; C Denier; A Joutel; M Cecillon; C Lescoat; K Vahedi; F Darcel; E Vicaut; M G Bousser; E Tournier-Lasserve
Journal:  N Engl J Med       Date:  2001-07-05       Impact factor: 91.245

2.  Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.

Authors: 
Journal:  Cephalalgia       Date:  1988       Impact factor: 6.292

3.  Migraine in the United States: epidemiology and patterns of health care use.

Authors:  R B Lipton; A I Scher; K Kolodner; J Liberman; T J Steiner; W F Stewart
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

4.  Brain infarction in young men.

Authors:  R J Burns; P C Blumbergs; M R Sage
Journal:  Clin Exp Neurol       Date:  1979

5.  Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study.

Authors:  Lilja S Jónsdóttir; Nikulás Sigfússon; Vilmundur Gudnason; Helgi Sigvaldason; Gudmundur Thorgeirsson
Journal:  J Cardiovasc Risk       Date:  2002-04

6.  Ischemic stroke and active migraine.

Authors:  D Milhaud; J Bogousslavsky; G van Melle; P Liot
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

Review 7.  The cerebellum and migraine.

Authors:  Maurice Vincent; Nouchine Hadjikhani
Journal:  Headache       Date:  2007-06       Impact factor: 5.887

8.  Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study.

Authors:  E Sigurdsson; G Thorgeirsson; H Sigvaldason; N Sigfusson
Journal:  Ann Intern Med       Date:  1995-01-15       Impact factor: 25.391

9.  Stroke and migraine--the spectrum of cause and effect.

Authors:  Kenneth Michael A Welch
Journal:  Funct Neurol       Date:  2003 Jul-Sep

10.  Migraine as a risk factor for subclinical brain lesions.

Authors:  Mark C Kruit; Mark A van Buchem; Paul A M Hofman; Jacobus T N Bakkers; Gisela M Terwindt; Michel D Ferrari; Lenore J Launer
Journal:  JAMA       Date:  2004-01-28       Impact factor: 56.272

View more
  78 in total

1.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  Arterial stiffness, pressure and flow pulsatility and brain structure and function: the Age, Gene/Environment Susceptibility--Reykjavik study.

Authors:  Gary F Mitchell; Mark A van Buchem; Sigurdur Sigurdsson; John D Gotal; Maria K Jonsdottir; Ólafur Kjartansson; Melissa Garcia; Thor Aspelund; Tamara B Harris; Vilmundur Gudnason; Lenore J Launer
Journal:  Brain       Date:  2011-11       Impact factor: 13.501

Review 3.  Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis.

Authors:  Pamela M Rist; Hans-Christoph Diener; Tobias Kurth; Markus Schürks
Journal:  Cephalalgia       Date:  2011-04-21       Impact factor: 6.292

4.  Tonabersat: a cortical spreading depression inhibitor as potential pharmacologic prophylaxis in migraine with aura.

Authors:  Ivan Garza
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

5.  Migraine with aura in patients over 50 years of age: the Marseille’s registry.

Authors:  Anne Donnet; Clément Daniel; Loïc Milandre; Julie Berbis; Pascal Auquier
Journal:  J Neurol       Date:  2012-09       Impact factor: 4.849

Review 6.  Migraine and small vessel diseases.

Authors:  E Agostoni; A Rigamonti
Journal:  Neurol Sci       Date:  2012-05       Impact factor: 3.307

7.  Migraine as a risk factor for young patients with ischemic stroke: a case-control study.

Authors:  Yasin Abanoz; Yeşim Gülen Abanoz; Ayşegül Gündüz; Derya Uludüz; Birsen İnce; Burcu Yavuz; Baki Göksan
Journal:  Neurol Sci       Date:  2017-01-12       Impact factor: 3.307

8.  Are migraine and non-migrainous headache risk factors for stroke in the elderly? Findings from a 12-year cohort follow-up.

Authors:  J Norton; F Portet; A Gabelle; S Debette; K Ritchie; J Touchon; C Berr
Journal:  Eur J Neurol       Date:  2016-07-11       Impact factor: 6.089

9.  Type 2 Diabetes, Change in Depressive Symptoms Over Time, and Cerebral Small Vessel Disease: Longitudinal Data of the AGES-Reykjavik Study.

Authors:  Sytze P Rensma; Thomas T van Sloten; Jennifer Ding; Sigurdur Sigurdsson; Coen D A Stehouwer; Vilmundur Gudnason; Lenore J Launer
Journal:  Diabetes Care       Date:  2020-06-11       Impact factor: 19.112

10.  Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.

Authors:  Michael M Dowling; Michael J Noetzel; Mark J Rodeghier; Charles T Quinn; Deborah G Hirtz; Rebecca N Ichord; Janet L Kwiatkowski; E Steven Roach; Fenella J Kirkham; James F Casella; Michael R DeBaun
Journal:  J Pediatr       Date:  2014-02-13       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.